Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
A California dietary supplement manufacturer recently was ordered by a federal court to stop selling its products until the company comes into compliance with the FDA’s dietary supplement manufacturing regulations and other requirements listed in a ...
read more
Tuesday, January 04, 2022
Curia, formerly AMRI, has unveiled its messenger RNA (mRNA) solution, which includes discovery, process development and mRNA drug substance production, through large-scale lipid manufacturing, lipid nanoparticle (LNP) formulation and development for ...
read more
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced plans to expand its commercial manufacturing capacity at its Rensselaer, New York facility. The increased capability to flexibly manufacture ...
read more
Thursday, August 04, 2022
Curia has appointed Niall Condon as president of its Manufacturing Division. Condon will drive growth and be responsible for operations of Curia’s commercial manufacturing services and products, including API and Drug Product.
read more
Friday, December 04, 2020
CureVac and Wacker Chemie have signed a contract for the manufacturing of CureVac’s COVID-19 vaccine candidate CVnCoV.
read more
Monday, December 02, 2019
CureVac has received manufacturing authorization for clinical trial materials produced under GMP from Regierungspräsidium Tübingen for the company’s scaled up GMP III production suite.
read more
CURE Pharmaceutical has closed on the previously announced acquisition of Chemistry Holdings, a formulation technology company that is develops delivery systems for a variety of industries.
read more
CURE Pharmaceutical has named Dr. Vered Gigi, Vice President of Strategy and Business Development.
read more
CGT Catapult’s cell and gene therapy manufacturing center has been officially opened by the Business Secretary Greg Clark and Science Minister Sam Gyimah.
read more
Wednesday, February 22, 2012
NanoSonic Products, Inc., a wholly owned subsidiary of CTD Holdings, Inc., announced that the Company has signed a manufacturing agreement with Florida Biologix for the production of the sterile liquid form of its Trappsol Cyclo product, an orphan ...
read more
Thursday, February 10, 2022
Cryoport, Inc. has provided an update on resumption of activities at the New Prague facility. As previously announced, a fire occurred in a portion of the MVE Biological Solutions manufacturing facility located in New Prague, Minnesota on January 25,...
read more
Wednesday, November 29, 2017
Crown Bioscience and DSI announced the successful development of an enhanced method for preclinical obesity and type 2 diabetes studies in partnership.
read more
Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies, announced the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers.
read more
Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies announced the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers.
read more
Pharma event launches a range of packages for industry partners to implement charity giving.
read more